Jaguar Animal Health Inc
$ 1.78
4.71%
07 Nov - close price
- Market Cap 6,598,700 USD
- Current Price $ 1.78
- High / Low $ 2.10 / 1.63
- Stock P/E 0.05
- Book Value 3.60
- EPS 37.53
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.37 %
- ROE -3.19 %
- 52 Week High 33.25
- 52 Week Low 1.57
About
Jaguar Animal Health, Inc. (JAGX) is a commercial-stage biopharmaceutical company headquartered in San Francisco, focused on developing innovative prescription therapies for both human and animal health, with a primary emphasis on chronic gastrointestinal disorders and debilitating diarrhea. Utilizing proprietary technologies rooted in extensive research of the gastrointestinal microbiome, Jaguar Health is committed to delivering effective and sustainable healthcare solutions that enhance the quality of life for patients and their pets. As the demand for effective treatments in the gastrointestinal market continues to rise, Jaguar Health's advancements position it as a significant player in the biopharmaceutical landscape.
Analyst Target Price
$25.50
Quarterly Earnings
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-08-14 | 2025-04-07 | 2025-03-31 | 2024-11-13 | 2024-08-13 | 2024-04-01 | 2024-01-31 | 2023-11-14 | 2023-08-14 | 2023-04-28 | 2023-03-27 | 2022-11-14 |
| Reported EPS | -10.26 | -18.7722 | -125.8 | -1.05 | -4.04 | -0.07 | -33 | -0.55 | -0.69 | -2.3881 | -3.4297 | -9 |
| Estimated EPS | -0.28 | -10.82 | -18.5 | -2.37 | -1.2 | -0.03 | -73.8 | -1.23 | -1.53 | -0.04 | -9.75 | -5.62 |
| Surprise | -9.98 | -7.9522 | -107.3 | 1.32 | -2.84 | -0.04 | 40.8 | 0.68 | 0.84 | -2.3481 | 6.3203 | -3.38 |
| Surprise Percentage | -3564.2857% | -73.4954% | -580% | 55.6962% | -236.6667% | -133.3333% | 55.2846% | 55.2846% | 54.902% | -5870.25% | 64.8236% | -60.1423% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: JAGX
2025-09-23 11:00:00
MIAMI, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025.
2025-08-19 11:00:00
MIAMI, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025.
2025-07-15 11:00:00
MIAMI, July 15, 2025 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025.
2025-05-20 11:00:00
MIAMI, May 20, 2025 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025.
2025-03-25 11:00:00
MIAMI, March 25, 2025 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025.
2025-03-18 16:01:16
Jaguar Health shares are trading lower by 40.1% during Tuesday's session. The company announced a 1-for-25 reverse stock split of its common stock. Join Nic Chahine live on Wednesday, March 19, at 6 PM ET for a step-by-step breakdown of how to to capitalize on post-Fed volatility and manage risk ...
